• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Med Sci . Clinical Characteristics and Outcomes of 74 Patients With Severe or Critical COVID-19

tetano

Editor, Senior Moderator
Am J Med Sci


. 2020 Jun 1;S0002-9629(20)30232-9.
doi: 10.1016/j.amjms.2020.05.040. Online ahead of print.
Clinical Characteristics and Outcomes of 74 Patients With Severe or Critical COVID-19


Junli Li[SUP] 1 [/SUP], Ge Xu[SUP] 2 [/SUP], Heping Yu[SUP] 3 [/SUP], Xiang Peng[SUP] 4 [/SUP], Yongwen Luo[SUP] 5 [/SUP], Cheng'an Cao[SUP] 6 [/SUP]



Affiliations

Abstract

Background: The outbreak of the coronavirus disease (COVID-19) has led to a major concern and caused a pandemic globally. The goal of this study was to clarify the clinical characteristics of recovery and death in patients with severe or critical COVID-19.
Materials and methods: In this retrospective single-center study, clinical data were collected from 74 severe or critical COVID-19 patients in Wuhan Fourth Hospital between Jan. 25th and Feb. 26th, 2020. All patients were divided into a recovery group or a death group according to clinical outcomes, and the differences between the groups were compared.
Results: Of the 74 patients enrolled in the study, 48 (64.9%) were severe cases and 26 (35.1%) were critical cases. Sixty (81.1%) patients were recovered and 14 (18.9%) died. Compared with recovery patients, patients in the death group were older, and had higher incidences of hypertension, coronary disease and dyspnea at admission. Laboratory tests for lactate dehydrogenase, creatine kinase, myoglobin, brain natriuretic peptide and D-dimer indicated higher levels in the death group. The PaO[SUB]2[/SUB]:FiO[SUB]2[/SUB] ratio and minimum SpO[SUB]2[/SUB] were lower in the death group, and a higher proportion of these patients received noninvasive mechanical ventilation, invasive mechanical ventilation and extracorporeal membrane oxygenation treatment.
Conclusions: Elderly patients with comorbidities are at higher risk of severe COVID-19 or death. Patients with a low blood gas index and poor coagulation function at admission had a high mortality rate. For such patients, comprehensive treatment should be performed as soon as possible to improve the prognosis and reduce mortality.

Keywords: COVID-19; Clinical features; Coronavirus; SARS-CoV-2.
 
Back
Top Bottom